Journal of Hepatology
Volume 52, Issue 5 , Pages 681-689 , May 2010

In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence

  • Ludovic Ménard

      Affiliations

    • INSERM U889; Université de Bordeaux, F-33076 Bordeaux, France
    • Université de Bordeaux, Institut Fédératif de Recherches 66, F-33076 Bordeaux, France
    • L.M. and D.T. contributed equally to this work.
    • ,
  • Danièle Taras

      Affiliations

    • INSERM U889; Université de Bordeaux, F-33076 Bordeaux, France
    • Université de Bordeaux, Institut Fédératif de Recherches 66, F-33076 Bordeaux, France
    • L.M. and D.T. contributed equally to this work.
    • ,
  • Aude Grigoletto

      Affiliations

    • INSERM U889; Université de Bordeaux, F-33076 Bordeaux, France
    • Université de Bordeaux, Institut Fédératif de Recherches 66, F-33076 Bordeaux, France
    • ,
  • Valérie Haurie

      Affiliations

    • INSERM U889; Université de Bordeaux, F-33076 Bordeaux, France
    • Université de Bordeaux, Institut Fédératif de Recherches 66, F-33076 Bordeaux, France
    • ,
  • Alexandra Nicou

      Affiliations

    • INSERM U889; Université de Bordeaux, F-33076 Bordeaux, France
    • Université de Bordeaux, Institut Fédératif de Recherches 66, F-33076 Bordeaux, France
    • ,
  • Nathalie Dugot-Senant

      Affiliations

    • Université de Bordeaux, Institut Fédératif de Recherches 66, F-33076 Bordeaux, France
    • ,
  • Pierre Costet

      Affiliations

    • Université de Bordeaux, Animalerie spécialisée, F-33076 Bordeaux, France
    • ,
  • Benoît Rousseau

      Affiliations

    • Université de Bordeaux, Animalerie A2, F-33076 Bordeaux, France
    • ,
  • Jean Rosenbaum

      Affiliations

    • INSERM U889; Université de Bordeaux, F-33076 Bordeaux, France
    • Université de Bordeaux, Institut Fédératif de Recherches 66, F-33076 Bordeaux, France
    • CHU de Bordeaux, F–33076 Bordeaux, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 5 557 571 594; fax: +33 556 514 077.

Received 26 August 2009 ,Revised 5 December 2009 ,Accepted 9 December 2009.

References 

  1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–543
  2. Blanc J, Lalanne C, Plomion C, Schmitter J, Bathany K, Gion J, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics. 2005;5:3778–3789
  3. Rousseau B, Menard L, Haurie V, Taras D, Blanc J, Moreau-Gaudry F, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology. 2007;46:1108–1118
  4. Kanemaki M, Kurokawa Y, Matsu-ura T, Makino Y, Masani A, Okazaki K, et al. TIP49b, a new RuvB-like DNA helicase, is included in a complex together with another RuvB-like DNA helicase, TIP49a. J Biol Chem. 1999;274:22437–22444
  5. Wood MA, McMahon SB, Cole MD. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell. 2000;5:321–330
  6. Bauer A, Chauvet S, Huber O, Usseglio F, Rothbacher U, Aragnol D, et al. Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity. EMBO J. 2000;19:6121–6130
  7. Shen X, Mizuguchi G, Hamiche A, Wu C. A chromatin remodelling complex involved in transcription and DNA processing. Nature. 2000;406:541–544
  8. Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell. 2000;102:463–473
  9. Salzer U, Kubicek M, Prohaska R. Isolation, molecular characterization, and tissue-specific expression of ECP-51 and ECP-54 (TIP49), two homologous, interacting erythroid cytosolic proteins. Biochim Biophys Acta. 1999;1446:365–370
  10. Ammelburg M, Frickey T, Lupas AN. Classification of AAA+ proteins. J Struct Biol. 2006;156:2–11
  11. Iyer LM, Leipe DD, Koonin EV, Aravind L. Evolutionary history and higher order classification of AAA+ ATPases. J Struct Biol. 2004;146:11–31
  12. Jonsson ZO, Dhar SK, Narlikar GJ, Auty R, Wagle N, Pellman D, et al. Rvb1p and Rvb2p are essential components of a chromatin remodeling complex that regulates transcription of over 5% of yeast genes. J Biol Chem. 2001;276:16279–16288
  13. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA. 2004;101:12792–12797
  14. Etard C, Gradl D, Kunz M, Eilers M, Wedlich D. Pontin and Reptin regulate cell proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1. Mech Dev. 2005;122:545–556
  15. Bellosta P, Hulf T, Balla Diop S, Usseglio F, Pradel J, Aragnol D, et al. Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development. Proc Natl Acad Sci USA. 2005;102:11799–11804
  16. Jin J, Cai Y, Yao T, Gottschalk AJ, Florens L, Swanson SK, et al. A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex. J Biol Chem. 2005;280:41207–41212
  17. Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature. 2005;434:921–926
  18. Venteicher AS, Meng Z, Mason PJ, Veenstra TD, Artandi SE. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell. 2008;132:945–957
  19. Schmeichel KL, Bissell MJ. Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci. 2003;116:2377–2388
  20. Mueller-Klieser W. Tumor biology and experimental therapeutics. Crit Rev Oncol Hematol. 2000;36:123–139
  21. Haurie V, Ménard L, Nicou A, Touriol C, Metzler P, Fernandez J, et al. Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism. Hepatology. 2009;50:1871–1883
  22. Neaud V, Gillibert Duplantier J, Mazzocco C, Kisiel W, Rosenbaum J. Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism. J Biol Chem. 2004;279:5200–5206
  23. Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene. 2007;397:84–93
  24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–408
  25. Greiner DL, Shultz LD, Yates J, Appel MC, Perdrizet G, Hesselton RM, et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol. 1995;146:888–902
  26. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175–3182
  27. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol. 2003;77:8957–8961
  28. Deuschle U, Meyer WK, Thiesen HJ. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol. 1995;15:1907–1914
  29. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol. 2003;4:231
  30. Prochazka M, Gaskins HR, Shultz LD, Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA. 1992;89:3290–3294
  31. Matsukura S, Jones PA, Takai D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 2003;31:e77
  32. Matthess Y, Kappel S, Spankuch B, Zimmer B, Kaufmann M, Strebhardt K. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1. Oncogene. 2005;24:2973–2980
  33. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci USA. 2004;101:10380–10385
  34. Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cancer Res. 2006;66:10613–10620
  35. Ke N, Zhou D, Chatterton JE, Liu G, Chionis J, Zhang J, et al. A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing. Exp Cell Res. 2006;312:2726–2734
  36. Li L, Lin X, Staver M, Shoemaker A, Semizarov D, Fesik SW, et al. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res. 2005;65:7249–7258
  37. Taulli R, Scuoppo C, Bersani F, Accornero P, Forni PE, Miretti S, et al. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Res. 2006;66:4742–4749
  38. Hannon G, Rossi J. Unlocking the potential of the human genome with RNA interference. Nature. 2004;431:371–378
  39. Chan HM, Narita M, Lowe SW, Livingston DM. The p400 E1A-associated protein is a novel component of the p53–>p21 senescence pathway. Genes Dev. 2005;19:196–201
  40. Kubicka S, Trautwein C, Niehof M, Manns M. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations. Hepatology. 1997;25:867–873
  41. Rottbauer W, Saurin AJ, Lickert H, Shen X, Burns CG, Wo ZG, et al. Reptin and pontin antagonistically regulate heart growth in zebrafish embryos. Cell. 2002;111:661–672
  42. Feng Y, Lee N, Fearon ER. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res. 2003;63:8726–8734

PII: S0168-8278(10)00092-9

doi: 10.1016/j.jhep.2009.12.029

Journal of Hepatology
Volume 52, Issue 5 , Pages 681-689 , May 2010

Article Tools

* Image Usage & Resolution